Abpro Bio Co., Ltd.

Equities

A195990

KR7195990007

Industrial Machinery & Equipment

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-14 pm EDT			5-day change	1st Jan Change
484 ^KRW	-4.72%		-9.53%	-11.19%

2023	Abpro Bio Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
2022	Abpro Bio Co., Ltd. cancelled the acquisition of 30.911846% stake in Zinitix Co., Ltd. from Seoul Electronic Communication Co., Ltd., Wonwoo Kim, Soo-ah Kim.	CI

UGint Co., Ltd. announced that it has received KRW 6.5 billion in funding

November 21, 2017

On November 22, 2017, UGint Co., Ltd. (KOSDAQ: A195990) closed the transaction. The transaction included participation from Glowth & Value Fund 5, Lion International Co., Ltd. and individual investor, Lee, Seokho. The company amended the terms and has raised KRW 6,500,000,000. The bonds will carry coupon rate of 3%. The bonds are convertible into 4,890,895 common shares . The bonds will be convertible at fixed conversion price of KRW 1,329. The subscription date of the transaction is November 22, 2017.

Latest news about Abpro Bio Co., Ltd.

Abpro Bio Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Abpro Bio Co., Ltd. cancelled the acquisition of 30.911846% stake in Zinitix Co., Ltd. from Seoul Electronic Communication Co., Ltd., Wonwoo Kim, Soo-ah Kim.	22-12-15	CI
Abpro Bio Co., Ltd. agreed to acquire 30.911846% stake in Zinitix Co., Ltd. from Seoul Electronic Communication Co., Ltd., Wonwoo Kim, Soo-ah Kim for KRW 37 billion.	22-09-25	CI
Abpro Bio Co., Ltd. announced that it has received KRW 5.999999552 billion in funding	21-12-23	CI
Abpro Bio Co., Ltd. announced that it expects to receive KRW 4.99999895 billion in funding	21-10-13	CI
Abpro Bio Co., Ltd. announced that it has received KRW 15 billion in funding from Meritz Securities Co., Ltd., Investment Arm	21-06-17	CI
Abpro Bio Co., Ltd. announced that it expects to receive KRW 15 billion in funding from Meritz Securities Co., Ltd., Investment Arm	21-06-15	CI
KUKBO Logistics Co.,Ltd acquired 19.35% stake in Bog International Co., Ltd. from Abpro Bio Co., Ltd. for KRW 2.8 billion.	20-12-21	CI
Hwail Pharmaceutical Co.,Ltd. announced that it has received KRW 16.4999812 billion in funding from Osung Advanced Materials Co., Ltd., Abpro Bio Co., Ltd.	20-12-14	CI
Abpro Bio Co., Ltd. announced that it has received KRW 10 billion in funding from Korea Bond Investment Advisory Co., Ltd.	20-11-25	CI
Hwail Pharmaceutical Co.,Ltd. announced that it expects to receive KRW 16.4999812 billion in funding from Osung Advanced Materials Co., Ltd. and other investors	20-11-17	CI
An unknown buyer cancelled the acquisition of 75% stake in UG Asset Co., Ltd. from Abpro Bio Co., Ltd..	20-10-24	CI
Microtech Co.,Ltd cancelled the acquisition of 80% stake in Vitro Corporation from Abpro Bio Co., Ltd. from Abpro Bio Co., Ltd..	20-10-22	CI
Abpro Bio Co., Ltd. announced that it expects to receive KRW 10 billion in funding from Korea Bond Investment Advisory Co., Ltd.	20-10-21	CI
Abpro Bio Co., Ltd.(KOSDAQ:A195990) added to S&P Global BMI Index	20-09-21	CI
An unknown buyer agreed to acquire 75% stake in UG Asset Co., Ltd. from Abpro Bio Co., Ltd. for KRW 3.2 billion.	19-12-30	CI
Microtech Co.,Ltd agreed to acquire 80% stake in Vitro Corporation from Abpro Bio Co., Ltd. for KRW 6.8 billion.	19-11-28	CI
Abpro Bio International, Inc. announced that it has received KRW 18.6608 billion in funding from Abpro Bio Co., Ltd.	19-11-17	CI
Abpro Bio Co., Ltd. announced that it has received KRW 19.999999134 billion in funding	19-11-13	CI
Abpro Bio Co., Ltd. announced that it has received KRW 14 billion in funding	19-10-30	CI
Abpro Bio Co., Ltd. announced that it expects to receive KRW 14 billion in funding	19-10-28	CI
Abpro Bio Co., Ltd. announced that it expects to receive KRW 19.999997712 billion in funding	19-08-26	CI
Ugint CO., Ltd. announced that it has received KRW 14.322 billion in funding	19-08-22	CI
Ugint CO., Ltd. announced that it expects to receive KRW 14.322 billion in funding	19-07-10	CI
Ugint CO., Ltd. announced that it has received KRW 15 billion in funding	19-04-22	CI

Chart Abpro Bio Co., Ltd.

Duration

Period

More charts

Company Profile

Abpro Bio Co., Ltd., formerly Ugint Co., Ltd., is a Korea-based company engaged in machine tools manufacturing. The Company produces and distributes small sized machining centers for notebooks, smart phones, tablet personal computers, mobile phones, base plates, light emitting diode (LED) and light crystal display (LCD) television panels, automobile parts, motorbikes parts and aircraft parts. The Company also engages in original equipment manufacturing business (OEM). The Company operates its business within domestic markets and foreign markets such as China and Europe countries.

Sector

Industrial Machinery & Equipment

More about the company

Income Statement Evolution

More financial data

Sector Machine Tools

	1st Jan change	Capi.
ABPRO BIO CO., LTD.	-11.19%	99.31M
DMG MORI CO., LTD.	+53.38%	3.49B
SHENYANG MACHINE TOOL CO., LTD.	+9.51%	2.17B
NINGBO HAITIAN PRECISION MACHINERY CO.,LTD.	+10.25%	2.08B
KENNAMETAL INC.	-8.51%	1.89B
SHENZHEN YINGHE TECHNOLOGY CO., LTD	-14.75%	1.4B
OKUMA CORPORATION	+15.69%	1.4B
GUANGDONG CREATE CENTURY INTELLIGENT EQUIPMENT GROUP CORPORATION LIMITED	-4.27%	1.39B
QINGDAO GAOCE TECHNOLOGY CO., LTD	-24.03%	1.39B
QINCHUAN MACHINE TOOL & TOOL GROUP SHARE CO., LTD.	-18.23%	1.23B

Machine Tools